beta
TPIV
TapImmune Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
TapImmune Inc is an immuno-oncology company. The company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer.
Market Cap: 40.8 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.tapimmune.com
Shares Outstanding: 10.6 Million
Float: 5.52 Million
Dividend: 0.0 (0.0%)
Beta: -0.961025
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1144 trading days
From: 2014-03-25 To: 2018-10-17
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|---|---|---|---|---|---|
2016-09-16 | 12.0 | 1.0 | 12.0 |